Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Aberer

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Contact Dermatitis|June 20, 1998
Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergyA Schnuch, G A Westphal, M M Müller, et al.
Journal of Investigational Allergology & Clinical Immunology|May 30, 2009
Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter studyA L De Week, M L Sanz, P M Gamboa, et al.
Journal of Investigational Allergology & Clinical Immunology|October 30, 2009
Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosisA L De Weck, M L Sanz, P M Gamboa, et al.
Contact Dermatitis|September 1, 2005
The European standard series in 9 European countries, 2002/2003 -- first results of the European Surveillance System on Contact AllergiesW Uter, J Hegewald, W Aberer, et al.
Allergy|April 27, 2013
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paperK Brockow, L H Garvey, W Aberer, et al.
Allergy|May 3, 2014
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and updateT Zuberbier, W Aberer, R Asero, et al.
Allergy|June 6, 2014
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticariaT Zuberbier, W Aberer, R Asero, et al.
Allergy|May 5, 2016
Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position PaperK Brockow, W Aberer, M Atanaskovic-Markovic, et al.
Journal of Investigational Allergology & Clinical Immunology|November 8, 2023
Factors Affecting the Safety and Effectiveness of Venom ImmunotherapyL Arzt-Gradwohl, S A Herzog, W Aberer, et al.
Allergy|January 31, 2009
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda projectP-J Bousquet, P Demoly, A Romano, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Contact Dermatitis|June 20, 1998
Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergyA Schnuch, G A Westphal, M M Müller, et al.
Journal of Investigational Allergology & Clinical Immunology|May 30, 2009
Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter studyA L De Week, M L Sanz, P M Gamboa, et al.
Journal of Investigational Allergology & Clinical Immunology|October 30, 2009
Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosisA L De Weck, M L Sanz, P M Gamboa, et al.
Contact Dermatitis|September 1, 2005
The European standard series in 9 European countries, 2002/2003 -- first results of the European Surveillance System on Contact AllergiesW Uter, J Hegewald, W Aberer, et al.
Allergy|April 27, 2013
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paperK Brockow, L H Garvey, W Aberer, et al.
Allergy|May 3, 2014
The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and updateT Zuberbier, W Aberer, R Asero, et al.
Allergy|June 6, 2014
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticariaT Zuberbier, W Aberer, R Asero, et al.
Allergy|May 5, 2016
Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position PaperK Brockow, W Aberer, M Atanaskovic-Markovic, et al.
Journal of Investigational Allergology & Clinical Immunology|November 8, 2023
Factors Affecting the Safety and Effectiveness of Venom ImmunotherapyL Arzt-Gradwohl, S A Herzog, W Aberer, et al.
Allergy|January 31, 2009
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda projectP-J Bousquet, P Demoly, A Romano, et al.
Pageof 22